VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CGC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CGCCanopy Growth Corporation
$0.95$366M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

CGC logoCanopy Growth Corporation(CGC)Earnings, Financials & Key Ratios

CGC•NASDAQ
$0.95
Price updated Jul 7, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryCannabis and cannabinoid product companies
AboutCanopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.Show more
  • Revenue$285M+5.8%
  • EBITDA-$37M+50.5%
  • Net Income-$263M+56.0%
  • EPS (Diluted)-0.88+84.1%
  • Gross Margin24.48%-17.2%
  • EBITDA Margin-12.87%+53.2%
  • Operating Margin-25.69%+41.0%
  • Net Margin-92.38%+58.5%
  • ROE-44.38%+63.4%

CGC Price & Volume

Canopy Growth Corporation (CGC) stock price & volume — 10-year historical chart

Loading chart...

Persistent Operational Losses Challenge Canopy Growth Solvency

Investment Thesis • Updated 2025Q4

VerdictNegative: The company continues to report persistent operating losses
Growth:Mixed
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Regulatory and liquidity constraints

Key Thesis Takeaways

  • Canopy Growth Corporation continues to struggle with structural profitability, as evidenced by persistent operating losses and a volatile revenue stream that reached $71.2 million in 2025Q4.
  • While the company has successfully reduced its total debt from $693.3 million in 2023Q3 to $278.7 million in 2025Q4, the ongoing cash burn and negative retained earnings of $11.1 billion present significant long-term solvency risks.
  • Investors should remain cautious as the firm attempts to pivot toward an asset-light model while navigating a challenging regulatory environment and thin liquidity buffers.

Verdict Logic

including a $27.5 million deficit in 2025Q4, and maintains a precarious liquidity position with cash reserves declining to $364.7 million.

CGC Growth Metrics

Canopy Growth Corporation (CGC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years36.47%
5 Years-12.24%
3 Years-5.12%
TTM16.11%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM52.15%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM84.41%

Return on Capital

10 Years-20.5%
5 Years-25.89%
3 Years-12.51%
Last Year-8.2%

CGC Recent Earnings

Canopy Growth Corporation (CGC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 4/12 qtrs (36%)
Q3 2026Latest
Jun 15, 2026
Metric
Actual
Est
EPS
$0.17-183.3%
$0.06
Rev
$51M-4.1%
$53M
Q2 2026
May 29, 2026
Metric
Actual
Est
EPS
$0.94-1466.7%
$0.06
Rev
—
$53M
Q1 2026
Feb 6, 2026
Metric
Actual
Est
EPS
$0.13-218.6%
$0.04
Rev
$54M+5.2%
$52M
Q4 2025
Nov 7, 2025
Metric
Actual
Est
EPS
$0.01+90.9%
$0.11
Rev
$48M-6.4%
$51M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q3 2026LatestJun 15, 2026
$0.17vs $0.06-183.3%
$51Mvs $53M-4.1%
Q2 2026May 29, 2026
$0.94vs $0.06-1466.7%
—vs $53M
Q1 2026Feb 6, 2026
$0.13vs $0.04-218.6%
$54Mvs $52M+5.2%
Q4 2025Nov 7, 2025
$0.01vs $0.11+90.9%
$48Mvs $51M-6.4%
Based on last 12 quarters of dataView full earnings history →

Latest CGC News

Recent stock market news and headlines for Canopy Growth Corporation (CGC)

The Motley Fool·18h ago
Canopy Growth: Is Another Reverse Stock Split Inevitable?

A reverse stock split may be necessary for Canopy Growth to keep its stock price above $1 and be in compliance with Nasdaq listing requirements. Canopy Growth last did a reverse split in December 2023.

MarijuanaStocks·1 day ago
Top Canadian Marijuana Stock Picks For Investors Today

As the cannabis sector continues to grow, it has marijuana stock investors seeing green. There has been a long, volatile battle for most of the time cannabis companies have been publicly traded. Even during the moments when many used pot stocks to get quick profits, given how the sector once began. At one point, a great deal of hype and speculation fueled investors in taking up positions for particular cannabis stocks.

The Motley Fool·3 days ago
Could Canopy Growth Stock Deliver a 4X Gain? 1 Analyst Thinks So.

While the analyst backs his bull case with estimates and facts, it's hard to envision triple-digit percentage gains for this Canada-based cannabis stock. Even if you're bullish on the U.S. legalization trend, it's smarter to stick with marijuana stocks that have stronger fundamentals.

Zacks Investment Research·Jun 30, 2026
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: Here's Why

Canopy Growth Corporation (CGC) closed at $0.95 in the latest trading session, marking a -4.45% move from the prior day.

24/7 Wall Street·Jun 30, 2026
Cannabis's 280E Tax Trap May Finally Break. We've Heard That Before.

While cannabis investors finally have an expedited DEA administrative hearing on the calendar and a fresh Schedule III pathway in motion, Wall Street has stood at this exact intersection before.

Peers Comparison

Key metrics vs top competitors for Canopy Growth Corporation (CGC)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
CGC logoCGCCanopy Growth CorporationCurrent
$0.95$365.74M-1.535.8%-92.38%-44.38%—
ACB logoACBAurora Cannabis Inc.
$2.67$165.39M-1.77-6.37%-24.14%-13.4%—
TLRY logoTLRYTilray Brands, Inc.
$4.31$502.21M-0.134.84%-252.55%-136.55%—
CRON logoCRONCronos Group Inc.
$2.75$1.03B-112.2464.4%-0.98%-0.18%—
OGI logoOGIOrganigram Global Inc.
$0.97$136.23M-9.8216.42%-9.7%-6.76%—
STZ logoSTZConstellation Brands, Inc.
$136.88$23.38B14.24-10.47%20.14%22.3%—

Compare CGC vs Peers

Canopy Growth Corporation (CGC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ACB

Most directly comparable listed peer for CGC.

Scale Benchmark

vs STZ

Larger-name benchmark to compare CGC against a more recognizable public peer.

Peer Set

Compare Top 5

vs ACB, TLRY, CRON, OGI

CGC SEC Filings & Documents

Canopy Growth Corporation (CGC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Jun 15, 2026·SEC

Material company update

May 27, 2026·SEC

Material company update

May 15, 2026·SEC

10-K Annual Reports

3
FY 2026

Jun 15, 2026·SEC

FY 2025

May 30, 2025·SEC

FY 2024

May 30, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Feb 6, 2026·SEC

FY 2025

Nov 7, 2025·SEC

FY 2025

Aug 8, 2025·SEC

Get notified when CGC posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CGC Frequently Asked Questions

Canopy Growth Corporation (CGC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Canopy Growth Corporation's revenue?

Canopy Growth Corporation (CGC) reported $312.3M in revenue for fiscal year 2025. This represents a 56892786% increase from $0.0M in 2009.

How fast is Canopy Growth Corporation growing?

Canopy Growth Corporation (CGC) grew revenue by 5.8% over the past year. This is steady growth.

Is CGC profitable?

Canopy Growth Corporation (CGC) reported a net loss of $286.2M for fiscal year 2025.

Dividend & Returns
What is CGC's return on equity?

Canopy Growth Corporation (CGC) has a return on equity (ROE) of -44.4%. Negative ROE indicates the company is unprofitable.

What is Canopy Growth Corporation's free cash flow?

Canopy Growth Corporation (CGC) had negative free cash flow of $76.9M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in CGC back in 2009?

Total return calculator · dividends reinvested · 17+ years of data

See returns →